BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 29301756)

  • 1. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation therapy in elderly patients with atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate the Implementation of New Guidelines (RAFTING).
    Pipilis A; Farmakis D; Kaliambakos S; Goudevenos J; Lekakis J;
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):545-549. PubMed ID: 26825445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).
    Barnett AS; Kim S; Fonarow GC; Thomas LE; Reiffel JA; Allen LA; Freeman JV; Naccarelli G; Mahaffey KW; Go AS; Kowey PR; Ansell JE; Gersh BJ; Hylek EM; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
    Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
    Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
    Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
    Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients.
    van Breugel HN; Gelsomino S; Lozekoot PW; Accord RE; Lucà F; Parise O; Crijns HJ; Maessen JG
    Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):313-20. PubMed ID: 24336783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".
    Lip GY; Nielsen PB; Skjøth F; Rasmussen LH; Larsen TB
    Can J Cardiol; 2015 Jan; 31(1):24-8. PubMed ID: 25547546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.